galanin   Click here for help

GtoPdb Ligand ID: 6129

Compound class: Peptide or derivative
Species: Pig
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES NCCCCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C)CC(C)C)Cc1ccc(cc1)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(CC)C)NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1ccc(cc1)O)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)CN)CC(C)C)CC(=O)N)CO)C)CC(C)C)CC(C)C)Cc1nc[nH]c1)C)CC(=O)O)CC(=O)N)Cc1nc[nH]c1)CCCN=C(N)N)CO)Cc1ccccc1)Cc1nc[nH]c1)CC(=O)O
Isomeric SMILES CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
InChI InChI=1S/C146H212N42O41/c1-15-75(10)119(186-122(205)77(12)165-128(211)101(51-84-60-153-68-161-84)181-142(225)110-31-24-42-188(110)116(199)65-160-123(206)93(43-71(2)3)172-129(212)95(45-73(6)7)173-131(214)98(49-82-34-38-88(193)39-35-82)169-114(197)63-158-121(204)76(11)164-140(223)108(66-189)185-136(219)105(55-112(150)195)178-130(213)96(46-74(8)9)182-144(227)120(79(14)191)187-139(222)100(167-113(196)58-148)50-83-59-157-90-28-20-19-27-89(83)90)143(226)183-107(57-118(202)203)138(221)179-104(54-111(149)194)135(218)177-102(52-85-61-154-69-162-85)133(216)171-92(30-23-41-156-146(151)152)126(209)184-109(67-190)141(224)175-99(47-80-25-17-16-18-26-80)132(215)176-103(53-86-62-155-70-163-86)134(217)180-106(56-117(200)201)137(220)170-91(29-21-22-40-147)125(208)174-97(48-81-32-36-87(192)37-33-81)124(207)159-64-115(198)168-94(44-72(4)5)127(210)166-78(13)145(228)229/h16-20,25-28,32-39,59-62,68-79,91-110,119-120,157,189-193H,15,21-24,29-31,40-58,63-67,147-148H2,1-14H3,(H2,149,194)(H2,150,195)(H,153,161)(H,154,162)(H,155,163)(H,158,204)(H,159,207)(H,160,206)(H,164,223)(H,165,211)(H,166,210)(H,167,196)(H,168,198)(H,169,197)(H,170,220)(H,171,216)(H,172,212)(H,173,214)(H,174,208)(H,175,224)(H,176,215)(H,177,218)(H,178,213)(H,179,221)(H,180,217)(H,181,225)(H,182,227)(H,183,226)(H,184,209)(H,185,219)(H,186,205)(H,187,222)(H,200,201)(H,202,203)(H,228,229)(H4,151,152,156)/t75-,76-,77-,78-,79+,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,119-,120-/m0/s1
InChI Key WVFODTWUOPGPAP-CIJSCKBQSA-N
References
1. Borowsky B, Walker MW, Huang LY, Jones KA, Smith KE, Bard J, Branchek TA, Gerald C. (1998)
Cloning and characterization of the human galanin GALR2 receptor.
Peptides, 19 (10): 1771-81. [PMID:9880084]
2. Burgevin MC, Loquet I, Quarteronet D, Habert-Ortoli E. (1995)
Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor.
J Mol Neurosci, 6 (1): 33-41. [PMID:8562318]
3. Fathi Z, Battaglino PM, Iben LG, Li H, Baker E, Zhang D, McGovern R, Mahle CD, Sutherland GR, Iismaa TP et al.. (1998)
Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.
Brain Res Mol Brain Res, 58 (1-2): 156-69. [PMID:9685625]
4. Fathi Z, Cunningham AM, Iben LG, Battaglino PB, Ward SA, Nichol KA, Pine KA, Wang J, Goldstein ME, Iismaa TP et al.. (1997)
Cloning, pharmacological characterization and distribution of a novel galanin receptor.
Brain Res Mol Brain Res, 51 (1-2): 49-59. [PMID:9427506]
5. Fitzgerald LW, Patterson JP, Conklin DS, Horlick R, Largent BL. (1998)
Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
J Pharmacol Exp Ther, 287 (2): 448-56. [PMID:9808667]
6. Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. (1994)
Molecular cloning of a functional human galanin receptor.
Proc Natl Acad Sci USA, 91 (21): 9780-3. [PMID:7524088]
7. Howard AD, Tan C, Shiao LL, Palyha OC, McKee KK, Weinberg DH, Feighner SD, Cascieri MA, Smith RG, Van Der Ploeg LH et al.. (1997)
Molecular cloning and characterization of a new receptor for galanin.
FEBS Lett, 405 (3): 285-90. [PMID:9108306]
8. Kolakowski Jr LF, O'Neill GP, Howard AD, Broussard SR, Sullivan KA, Feighner SD, Sawzdargo M, Nguyen T, Kargman S, Shiao LL et al.. (1998)
Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.
J Neurochem, 71 (6): 2239-51. [PMID:9832121]
9. Langel U, Pooga M, Kairane C, Zilmer M, Bartfai T. (1996)
A galanin-mastoparan chimeric peptide activates the Na+,K(+)-ATPase and reverses its inhibition by ouabain.
Regul Pept, 62 (1): 47-52. [PMID:8738882]
10. Parker EM, Izzarelli DG, Nowak HP, Mahle CD, Iben LG, Wang J, Goldstein ME. (1995)
Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells.
Brain Res Mol Brain Res, 34 (2): 179-89. [PMID:8750821]
11. Smith KE, Forray C, Walker MW, Jones KA, Tamm JA, Bard J, Branchek TA, Linemeyer DL, Gerald C. (1997)
Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
J Biol Chem, 272 (39): 24612-6. [PMID:9305929]
12. Smith KE, Walker MW, Artymyshyn R, Bard J, Borowsky B, Tamm JA, Yao WJ, Vaysse PJ, Branchek TA, Gerald C et al.. (1998)
Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
J Biol Chem, 273 (36): 23321-6. [PMID:9722565]
13. Sullivan KA, Shiao LL, Cascieri MA. (1997)
Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors.
Biochem Biophys Res Commun, 233 (3): 823-8. [PMID:9168941]